GTS Securities’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History

GTS Securities’s Portfolio KNTE Stock Details KNTE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-60,038	Closed	-$160K	–	4454
2024 Q1	$160K	Buy	+60,038	New	+$149K	﹤0.01%	3416

GTS Securities's KNTE Position: Q2 2024 in Review

GTS Securities sold out of Kinnate Biopharma Inc. Common Stock (KNTE) in Q2 2024, closing a stake of 60,038 shares — an estimated $160K sold.

GTS Securities first reported a position in KNTE in Q1 2024 and held it in 1 quarter. The position peaked at $160K in Q1 2024. 0 funds tracked by Wall St. Rank hold KNTE as of Q2 2024.

GTS Securities reported no remaining Kinnate Biopharma Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
GTS Securities sold 60,038 Kinnate Biopharma Inc. Common Stock shares in Q2 2024, an estimated $160K.
GTS Securities first reported a position in Kinnate Biopharma Inc. Common Stock in Q1 2024 and held it in 1 quarter.
GTS Securities's Kinnate Biopharma Inc. Common Stock position peaked at $160K in Q1 2024.
0 funds tracked by Wall St. Rank held Kinnate Biopharma Inc. Common Stock as of Q2 2024.

Based on GTS Securities's 13F filing for Q2 2024, filed 14 Aug 2024.